INTRODUCTION
Human immunodeficiency virus (HIV) type 1 (HIV-1), HIV type 2 (HIV-2), and simian immunodeficiency virus (SIV) infect many types of target cells. The infection is mediated by CD4 as the first receptor, and one of several G protein-coupled receptors (GPCRs), especially chemokine receptors such as CXCR4 and CCR5, as a coreceptor (Dimitrov, 1997) . T-cell-line-tropic (T-tropic) HIV-1 strains use an ␣-chemokine receptor, CXCR4, as a coreceptor (X4 HIV-1) , while macrophagetropic (M-tropic) HIV-1 strains use a ␤-chemokine receptor, CCR5, as a coreceptor (R5 HIV-1) Choe et al., 1996; Doranz et al., 1996; Dragic et al., 1996) . Dual-tropic HIV-1 strains that can infect both T-cell lines and macrophages efficiently use both CCR5 and CXCR4 (R5X4 HIV-1) and occasionally other ␤-chemokine receptors, CCR2b and CCR3 Doranz et al., 1996; Simmons et al., 1996; Sol et al., 1997) . Several Tor M-tropic HIV-1 strains were also reported to use a putative CKR, STRL33/Bonzo, as a coreceptor (Alkhatib et al., 1996; Liao et al., 1997) . Human cytomegalovirus (CMV)-encoded CKR, US28, acts as a coreceptor for several HIV-1 strains . More recently, it was reported that CCR8 is a coreceptor for diverse HIV-1 and SIV strains (Jinno et al., 1998; Rucker et al., 1997) . We previously reported that CCR8 and GPR1 can be used by a variant type of HIV-1, GUN1v, which was adapted to replication in brain-derived fibroblast-like BT-3 cells or a CD4-transduced glioma cell line, U87/CD4 (Jinno et al., 1998; Shimizu et al., 1999a) . APJ, an orphan receptor, was previously identified as a coreceptor for several T-tropic and dual-tropic HIV-1 strains (Choe et al., 1998; Zhang et al., 1998) .
HIV-2 strains were also shown to use several CKRs such as CXCR4, CCR3, and CCR5 as coreceptors (Bron et al., 1997; Sol et al., 1997) . Like HIV-1 strains, primary HIV-2 isolates, which were propagated in cultured peripheral blood mononuclear cells from asymptomatic carriers, use CCR5 or CCR3, but not CXCR4, while primary isolates from AIDS patients at advanced stages use CXCR4, but not CCR3 and CCR5 (Sol et al., 1997) . On the other hand, there are reports showing that primary HIV-2 isolates can use a broad range of coreceptors, including CCR1, CCR2b, CCR3, CCR5, and CXCR4 (Bron et al., 1997; McKnight et al., 1998) . HIV-2ROD, a T-cellline-adapted (T-tropic) isolate, is particularly promiscuous in coreceptor usage and induces fusion of CD4-positive cells expressing CCR1, CCR2b, CCR3, CCR5, CXCR2, or CXCR4 in cell-cell fusion assay, although it uses CCR3 and CXCR4, but not CCR1, CCR2b, CXCR2, or CCR5, in cell-free virus infection (Bron et al., 1997; McKnight et al., 1998) . ROD/B, a variant of HIV-2 that efficiently infects some types of cells lacking CD4, uses CXCR4, CCR3, or an orphan receptor V28 in the absence of CD4 (Endres et al., 1996; Reeves et al., 1997) . Furthermore, many primary HIV-2 strains were reported to infect CCR5-or CXCR4-positive cells lacking CD4 (Reeves et al., 1999) . These data suggest that the patterns of coreceptor usage are more complex for HIV-2 than for HIV-1.
Infection of T cells with SIV strains can be inhibited by natural CCR5 ligands, MIP-1␣, MIP-1␤, and RANTES (Cocchi et al., 1995) , and thus CCR5 has been identified to function as a coreceptor for SIV infection Edinger et al., 1997a; Marcom et al., 1997) . As for coreceptor usage of cell-free viruses, the utilization of the following was previously reported: CXCR4 by SIVmndGB-1 (Schols and De Clercq, 1998) ; CCR5 by several SIVs Edinger et al., 1997a; Marcom et al., 1997) ; CCR8 by SIVmac316 and SIVmac17E-Fr (Rucker et al., 1997) ; STRL33/BONZO by SIVmac239, SIVmac1A11, and SIVagmTYO-1 Deng et al., 1997) ; GPR1 by SIVmac239 ; and GPR15 by SIVmac239, SIVmac1A11, and SIVagmTYO-1 (Deng et al., 1997; Farzan et al., 1997) . In addition, APJ has been identified to act as a coreceptor for SIVmac316 infection (Choe et al., 1998) . Moreover, the neurovirulent strain SIVmac/17E-Fr can replicate well in brain capillary endothelial cells lacking CD4 (Mankowski et al., 1994) : CCR5 acts as a primary receptor, i.e., CD4-independent receptor, for this infection (Edinger et al., 1997b) . These reports indicate that the GPCR usage as a coreceptor and the requirement of CD4 as a primary receptor are complicated not only for HIV-2 but also for SIV infection. In cell-cell fusion assays, coreceptor usages of HIV/SIV strains have been reported to be wider than those in infection assays of cell-free viruses.
To more precisely examine the roles of CD4 and GPCRs in the infection with T-cell-line-adapted (T-tropic) HIV-2 and SIV strains, we infected various NP-2 and NP-2/CD4 cell lines, previously introduced with one of the coreceptors (Soda et al., 1999) , with several HIV-2 and SIV strains. The results showed that all HIV-2 strains that used multiple GPCRs as coreceptors infected CD4-negative cells in the presence of soluble CD4 (sCD4), and that only CCR5 or CXCR4 acted as a cellular CD4-independent coreceptor for promiscuous HIV-2 strains or SIVmnd.
RESULTS
Resistance of NP-2 and NP-2/CD4 cells to HIV-1, HIV-2, and SIV entry
To determine the coreceptor usage of HIV-1 (Ba-L, IIIB, and GUN1v), HIV-2 (CBL-20, CBL-21, CBL-23, GH-1, ROD, and SBL6669), or SIV (agm, mac, and mnd) strains using NP-2 and NP-2/CD4 cells, we examined whether these cells were resistant to infection with these viruses. Viral antigens were not expressed in these cells after infection of HIV-1, HIV-2, or SIV ( Fig. 1) as previously described in part (Soda et al., 1999) . Virus entry into NP-2 and NP-2/CD4 cells was further determined by PCR amplification using specific primers for HIV/SIV. No signal was detected after infection of NP-2 and NP-2/CD4 cells with three HIV-1, six HIV-2, or three SIV strains, while ␤-globinspecific bands were detected after PCR of each sample (data not shown). Thus NP-2 and NP-2/CD4 cells were confirmed by PCR to be resistant to all of the HIV-1, HIV-2, and SIV strains used in this study.
Establishment of GPCR-expressing NP-2 and NP-2/CD4 sublines NP-2/CD4 sublines stably expressing one of the human GPCRs, CCR3, CCR5, CCR8, CXCR4, GPR1, or APJ, were established as described elsewhere (Jinno et al., 1998; Soda et al., 1999) . CD4-negative NP-2 sublines expressing one of these GPCRs were also established in a similar way. The expression of CCR3, CCR5, CCR8, CXCR4, GPR1, or APJ mRNA was confirmed by RT-PCR to detect their specific mRNA (data not shown). Using anti-CD4 (Nu-TH/I), anti-CXCR4 (12G5), anti-CCR3 (7B11), or anti-CCR5 (2D7) monoclonal antibody (MAb), we further evaluated the expression of CD4, CXCR4, CCR3, or CCR5 on these NP-2 and NP-2/CD4 sublines by flow cytometry (FCM) ( Table 1) . FCM results showed that transduced genes CD4, CCR3, CCR5, and CXCR4 were specifically expressed on the surface of NP-2 and NP-2/CD4 sublines as described previously (Soda et al., 1999) , suggesting that our system to express CCR8, GPR1, and APJ also functioned well.
Coreceptors for infection of HIV-2 strains
We confirmed that NP-2/CD4 cells expressing CCR3, CCR5, CCR8, CXCR4, or GPR1 showed expected susceptibilities to HIV-1 strains (Table 2 and Fig. 1 ) as previously reported (Shimizu et al., 1999a; Soda et al., 1999) . APJ was not used by these three HIV-1 strains (Fig. 1) .
Next we examined GPCR usages of six HIV-2 strains. IFA performed within 10 days after infection showed that the abilities of these viruses to infect GPCR-expressing NP-2/CD4 sublines varied markedly (Fig. 1) . That is, dual (T-and M-)-tropic CBL-20 and CBL-21 strains only plated onto NP-2/CD4/CXCR4 cells, but not onto NP-2/CD4/CCR5 cells at all, while CBL-23, GH-1, ROD, and SBL6669 strains used multiple GPCRs, such as CCR3, CCR5, CCR8, CXCR4, GPR1, or APJ as coreceptors. CBL-23 and ROD strains efficiently infected all sublines including NP-2/CD4/APJ cells. GH-1 and SBL6669 strains showed different types of infectivities. The GH-1 strain efficiently used CCR5, CCR8, and GPR1, but not CXCR4, CCR3, or APJ (Fig. 1) . The SBL6669 strain efficiently infected NP-2/ CD4 cells expressing CCR3 or CXCR4, and to a lesser extent NP-2/CD4 cells expressing CCR8, GPR1, or APJ. Furthermore, this strain did not plate onto NP-2/CD4/ CCR5 cells at all (Fig. 1) . Thus APJ functioned well as an HIV-2 coreceptor.
Syncytium formation after infection with HIV-2
Since the coreceptors are used for cell fusion, we assessed the syncytium formation activities of the HIV-2 strains. The cultures with high percentages (e.g., Ͼ30%) of viral antigen-positive cells always showed marked syncytium formation, whereas weakly infected cells (e.g., Ͻ10% positive) formed a few syncytia as summarized in 
Note. Ratios of antigen-positive cells (%) (means Ϯ SD) were determined by flow cytometry as described under Materials and Methods. a Monoclonal antibodies (MAbs) used were as follows: anti-CD4, Nu-TH/I; anti-CCR3, 7B11; anti-CCR5, 2D7; anti-CXCR4, 12G5. b Ϫ, negative (Ͻ5%). Table 2 . Virus production into culture fluids after infection with HIV-2 was detectable by RT assays (data not shown). The results of syncytium formation assays ( Table  2 ) and those of RT assays were well correlated with those of IFA shown in Fig. 1 .
Coreceptors for infection of SIVs
We then investigated whether GPCR-expressing NP-2/CD4 sublines were also susceptible to infection by three SIV strains, SIVagmTYO-1, SIVmac251, and SIVmndGB-1. As shown in Fig. 1 , high percentages of CCR5-or GPR1-expressing cells inoculated with SIVagm, SIVmac, and SIVmnd were IFA-positive for viral antigens. SIVmnd also replicated well in NP-2/ CD4/CXCR4 cells as reported (Schols and De Clercq, 1998) and poorly in NP-2/CD4/APJ, NP-2/CD4/CCR3, and NP-2/CD4/CCR8 cells. SIVagm infected NP-2/CD4/ CXCR4 cells with a low efficiency (IFA-positive cells, 10%) (Fig. 1) .
Numerous syncytia were formed in CCR5-or GPR1-expressing NP-2/CD4 cells infected with all three SIV strains and in NP-2/CD4/CXCR4 cells infected with SIVmnd, as summarized in Table 2 . Productive infection of NP-2/CD4 sublines with SIV was also confirmed by RT assays of culture supernatants of inoculated cells (data not shown).
CCR5-mediated, CD4-independent infection of SIVmnd and HIV-2GH-1
CCR5 has been shown to facilitate the CD4-independent infection of brain capillary endothelial cells with the SIVmac/17E-Fr strain (Edinger et al., 1997b) . We thus investigated the CCR5 usage of HIV-2 and SIV strains in a CD4-independent manner. Although CCR5 has been reported not to function as a coreceptor for SIVmndGB-1 (Schols and De Clercq, 1998) , the SIVmnd strain was found to efficiently infect NP-2/CCR5 cells in the presence or absence of sCD4 ( Fig. 2A) . The HIV-2 strain GH-1 infected NP-2/CCR5 cells only in the presence of sCD4 ( Fig. 2A ). Large and small syncytia were formed in NP-2/CCR5 cells after infection with SIVmnd and HIV-2GH-1, respectively (Fig. 2B , panels b and c). RT assays also showed that NP-2/CCR5 cells were productively infected with SIVmnd, whereas infection of NP-2/CCR5 cells with HIV-2GH-1 required the presence of sCD4 (Fig. 3 ).
CXCR4 as a primary receptor for HIV-2 strains
CXCR4 has been reported to act as a primary receptor for the ROD strain of HIV-2 (Endres et al., 1996; Reeves et al., 1997) . Two out of six HIV-2 strains, ROD and SBL6669, efficiently infected CD4-negative NP-2/CXCR4 cells ( Fig.  2A) . The CBL-23 strain did infect NP-2/CXCR4 cells in the presence of sCD4, but with a low efficiency ( Fig. 2A) . 
Results of syncytium formation assay were consistent with those of IFA shown in Figs. 1 and 2. As for cellular CD4-independent infection, all of the CD4-negative sublines were examined and only positive results are shown.
a Symbols: Ϫ, negative results (no syncytium); ϩ, 1-50; ϩϩ, 50-100, ϩϩϩ, 100-200, ϩϩϩϩ, Ͼ200 syncytia per well in 12-well plates during 10 days after infection.
b Syncytium formation only in the presence of human sCD4 at 10 g/ml. c Syncytium formation in the presence and absence of sCD4. d NP-2/APJ cells were examined only in the absence of sCD4.
Numerous syncytia were observed in NP-2/CXCR4 cells infected with the ROD and SBL6669 strains (Fig. 2B , panels e and f). RT assays also showed that NP-2/CXCR4 cells were productively infected with HIV-2 (Fig. 3) . These results indicate that the NP-2 cell system functioned well for analyses of CD4-independent infection of HIV/SIV. HIV-2CBL-20 and HIV-2CBL-21, and two SIV strains (agm and mac) as well as three HIV-1 strains did not infect NP-2/CXCR4 or NP-2/CCR5 cells ( Fig. 2A) . NP-2/ CCR3, NP-2/CCR8, NP-2/GPR1, or NP-2/APJ cells were resistant to all of the HIV/SIV strains we tested (Table 2 , and data not shown). Thus, only NP-2/CCR5 and NP-2/ CXCR4 cells were susceptible to some HIV-2 and SIV strains in the presence or absence of sCD4.
Inhibition of CD4-independent infection by monoclonal antibodies
Anti-CCR5 MAb showed over 95% inhibition of the infection of NP-2/CCR5 cells with the SIVmnd strain at 1 g/ml, while the anti-CXCR4 MAb 12G5 exhibited little inhibitory effect on this infection (Fig. 4A) . Next, we investigated the inhibitory effects of CCR5 ligands on infection of NP-2/CCR5 cells with SIVmnd. As shown in Fig.  4B , MIP-1␣, MIP-1␤, and RANTES at 250 ng/ml markedly inhibited the infection of NP-2/CCR5 cells with SIVmnd. In contrast, a natural ligand for CCR3, eotaxin, had little inhibitory effect on the infection of SIVmnd (Fig. 4B ).
These findings indicate that CCR5 was really used in the infection of NP-2/CCR5 cells with SIVmnd.
The anti-CXCR4 MAb 12G5 was confirmed to block the infection of NP-2/CXCR4 cells with both ROD and SBL6669 strains (Fig. 4C ): 12G5 MAb at 5 g/ml markedly inhibited the infection of NP-2/CXCR4 cells with either ROD or SBL6669 strain. Anti-CCR5 MAb 2D7 had little effect on this infection (Fig. 4) .
Effect of low temperature on CD4-independent infection
NP-2/CD4/CXCR4 or NP-2/CXCR4 cells were inoculated with HIV-2ROD or SIVmnd at either 37 or 4°C and incubated for 1 h. The cells were washed extensively and cultured for up to 10 days. NP-2/CD4/CXCR4 cells were infected with both virus strains: their plating was severalfold more efficient at 37°C than at 4°C (Fig. 5A) . As for CD4-independent infection, only HIV-2ROD plated onto NP-2/CXCR4 cells: the virus bound to CD4-negative NP-2/CXCR4 cells even at 4°C (Fig. 5B) , suggesting that conformational change of Env protein might not be necessary for virus binding, because such changes can hardly be expected to occur at 4°C. The plating efficiency of HIV-2ROD to CD4-negative NP-2/CD4 cells was also several-fold higher at 37°C than at 4°C (Fig. 5B) .
Next NP-2/CD4/CCR5 and NP-2/CCR5 cells were inoculated with HIV-2ROD or SIVmnd at either 37 or 4°C: their plating efficiencies were several-fold higher at 37°C than at 4°C (Figs. 5C and 5D) Only SIVmnd plated onto CD4-negative NP-2/CCR5 cells (Fig. 5D) . Thus, HIV-2ROD and SIVmnd could use both CXCR4 and CCR5 as coreceptors in the presence of cellular CD4 (Figs. 5A and 5C ), but only CXCR4 and CCR5, respectively, functioned as entry factors in CD4-independent infection (Figs. 5B and  5D ).
More important, there was a difference in the infection efficiency between CCR5-and CXCR4-expressing NP-2 cells by HIV-2ROD and SIVmnd. HIV-2ROD plated about 10-fold more efficiently onto NP-2/CD4/CXCR4 cells than onto NP-2/CD4/CCR5 cells, whereas SIVmnd plated much more efficiently onto NP-2/CD4/CCR5 cells than onto NP-2/CD4/CXCR4 cells (Figs. 5A and 5C ). These findings suggest that the most efficient coreceptor in a CD4-dependent infection can be a CD4-independent coreceptor.
Cell-to-cell infection of CD4-negative cells
In CD4-independent infection of cell-free viruses, HIV-2ROD and SIVmnd used only CXCR4 and CCR5, respectively, but not both as the primary receptor (Fig. 5) . Next we examined whether the cells are resistant to HIV-2 or SIV when they are cocultured with HIV-2-or SIV-producing cells. C8166 cells were infected with either HIV-2ROD or SIVmnd. NP-2/CXCR4 and NP-2/CCR5 cells as well as NP-2/CD4 and NP-2 cells were cocultured with infected C8166 cells. Twelve days after cocultivation, most if not all C8166 cells were lysed and disappeared. Then cell smears were made and examined by IFA. Almost all NP-2/CXCR4 and NP-2/CCR5 cells were infected with HIV-2ROD and SIVmnd, respectively (Fig. 6) . Next C8166/ CCR5 cells were infected with HIV-2ROD and cocultivated with NP-2/CXCR4, NP-2/CCR5, or NP-2/CCR3 cells. Most, and only, NP-2/CXCR4 cells were positive for HIV-2 antigens by 4-8 days after coculture (data not shown). Even in cell-to-cell infection of HIV-2/SIV, only CCR5 and CXCR4 functioned as a CD4-independent receptor for SIVmnd and HIV-2ROD, respectively.
V3 loop sequences of HIV-2/SIV and their coreceptor usages
To identify amino acids in the V3 loop, which is critical for the determination of coreceptor usage, we sequenced the V3 loops of all of the HIV-2/SIV strains used in this study (Table 3 ). The V3 DNA sequences (three clones from each strain) derived from HIV-2/SIV strains that had been maintained in our laboratory were identical to those present in the GenBank database (data for the CBL-20 strain are not available), except that one amino acid residue in the ROD strain was different from the reported sequence of ROD (Table 3) . GH-1 and CBL-23 strains with a few amino acid substitutions from the consensus sequences of HIV-2 V3 were able to use multiple coreceptors. We could not point out a specific amino acid or a specific site that could be important for determination of coreceptor usage.
DISCUSSION
A T-tropic HIV-1 strain, IIIB, used only CXCR4 as an efficient coreceptor, and an M-tropic HIV-1 strain, Ba-L, used CCR5 as a coreceptor (Fig. 1) . The HIV-1GUN1v strain used multiple GPCRs as coreceptors ( Fig. 1 and Table 2 ) as reported (Shimizu et al., 1999a,b; Soda et al., 1999) . In the case of HIV-2, we observed that all six HIV-2 strains replicated well in T-cell lines, such as C8166 or Molt-4, and macrophages (data not shown), but CBL-20 and CBL-21 strains used CXCR4 but not CCR3 or CCR5. The other strains, CBL-23, GH-1, ROD, and SBL6669, used several coreceptors, such as CXCR4, CCR3, CCR5, CCR8, GPR1, or APJ, but the SBL6669 strain could not use CCR5. Thus, the usage by HIV-2 strains of coreceptors expressed in NP-2/CD4 cells does not appear to be well correlated with the cell tropism for macrophages. By the use of findings shown in Fig. 1 and Table 2 , T-cell-lineadapted (T-tropic) HIV-2 strains can be grouped into two types according to their abilities to infect NP-2/CD4 sublines expressing GPCRs. The first group including CBL-20 and CBL-21 is X4 HIV-2, and the second group is promiscuous for coreceptor usage: SBL6669 and GH-1 strains are moderately promiscuous and CBL-23 and ROD strains are highly promiscuous.
Although three SIV strains, SIVagm, SIVmac, and SIVmnd, also replicated well in C8166 or Molt-4 T-cell lines, only SIVmnd efficiently used CXCR4 as a coreceptor for infection (Fig. 1) as reported (Schols and De Clercq, 1998) . CCR5, which is not expressed in either Molt-4 or C8166 cells, was shown to function as a coreceptor for almost all SIV strains Edinger et al., 1997a; Marcon et al., 1997) , except for SIVmnd (Schols and De Clercq, 1998) . These findings suggest that an alternative coreceptor should also be used for infection of T-cell lines with SIVs. It has been reported that GPR1 is a coreceptor for SIVmac infection and is a cell-cell fusion factor for SIVagm (Edinger et al., 1998) . In this study, cell-free SIVagm and SIVmnd were shown to efficiently use GPR1 as a coreceptor (Fig. 1) . Other GPCRs such as CXCR4, CCR3, CCR8, or APJ did not act as efficient coreceptors for SIVagm and SIVmac (Fig. 1) . GPR1 was found to be expressed in C8166 T cells (Shimizu et al., 1999a) . Therefore GPR1 may play an important role in infection of T-cell lines or primary T cells with SIVagm and SIVmnd as well as SIVmac.
Recently, CCR5 was reported to function as a primary receptor for the neurovirulent SIVmac/17E-Fr strain (Edinger et al., 1997b) . In this study we found that SIVmnd, but neither SIVmac nor SIVagm, could use CCR5 to infect NP-2 cells lacking CD4 (Figs. 1-3 ), although these viruses could efficiently infect NP-2/CD4/CCR5
FIG. 4. Inhibitory effects of monoclonal antibodies and CCR5
ligands on infection of SIVmnd and HIV-2. NP-2/CCR5 (A and B) and NP-2/CXCR4 (C) cells were preincubated with anti-CCR5 MAb, 2D7, anti-CXCR4 MAb, 12G5, or CCR5 ligands, MIP-1␣, MIP-1␤, or RAN-TES, at the indicated concentrations, and then were infected with SIVmnd (A and B) or HIV-2 (ROD or SBL6669) (C). Inhibition rates (%) were calculated as described under Materials and Methods. Representative data of one experiment from three independent experiments are shown.
cells. SIVmnd showed a broader coreceptor use than that of both SIVagm and SIVmac (Table 2 and Fig. 1) . HIV-2GH-1 also used CCR5 to infect CD4-negative NP-2 cells, but it required sCD4 (Fig. 2) . Although CXCR4, CCR3, CCR5, CCR8, GPR1, or APJ was shown to be the coreceptor for some HIV-2 or SIV strains, only CXCR4 and CCR5 functioned as primary receptors for HIV-2 or SIV when expressed in CD4-negative NP-2 cells (Table  2) . Although HIV-1GUN1v was very promiscuous (as shown in Fig. 1 ), this strain, as well as other promiscuous HIV-1 strains (data not shown), always required cellular CD4 for entry, so far as we tested.
Dependency of specific coreceptors, either CXCR4 or CCR5, on the establishment of CD4-independent infection was strict. Although HIV-2ROD and SIVmnd efficiently used both CXCR4 and CCR5 in the presence of cellular CD4, only one of them functioned as a CD4-independent coreceptor (Figs. 5 and 6 ). This may not be determined by the amounts of viruses inoculated to target cells, because even cell-to-cell infection could not overcome this restriction (Fig. 6) .
Plating efficiencies of HIV-2ROD and SIVmnd at 4°C were about 10-fold lower than those at 37°C in the presence of CD4 or even in the absence of CD4 (Fig. 5) . At 4°C the conformational change of Env protein is hardly thought to take place. This change ensures a coreceptor-binding region of these viruses to be exposed on the surface of virions. The surface structure of Env proteins of these virus strains, which use CCR5 or CXCR4 in the CD4-independent way, may be different from that of viruses which require CD4 for the entry. Our findings suggest that a CXCR4-binding region of HIV-2ROD and a CCR5-binding region of SIVmnd, but not the other coreceptor-binding regions, may be exposed on the surface of virions. Two possibilities may explain the difference in recognition of coreceptors by the HIV-2/SIV strains in the absence of CD4: (1) the region of Env protein that binds to CXCR4 or CCR5 is different from strain to strain; and (2) the binding affinity of an exposed region of Env protein of each virus strain to a GPCR is different and critical, and a specific combination showing a high enough affinity will function as a coreceptor.
There may be correlation between the promiscuity of HIV-2 strains and the cellular CD4-independent infection. In this study four out of four promiscuous HIV-2 strains, but neither of two X4 HIV-2 strains, could infect CCR5-or CXCR4-positive, CD4-negative NP-2 cells in the presence of sCD4. Nevertheless, the SBL6669 strain that was less promiscuous in coreceptor usage than the CBL-23 strain (Fig. 1 ) did efficiently infect NP-2/CXCR4 cells in the absence of sCD4, whereas the CBL-23 strain required sCD4, and its infection efficiency was still much lower than that of the SBL6669 strain ( Fig. 2A) . In general, there seems to be a tendency that a virus which can use multiple coreceptors is likely to infect cells in a CD4-independent way.
The V3 domain of the HIV-1 gp120 has been shown to be critical for ␤-chemokine-mediated blockade of infection (Cocchi et al., 1996) . This region was then demonstrated to be important in CCR5 usage by HIV-1: chimeric viruses containing the V3 region of an NSI virus on an SI virus background were shown to use CCR5 (Bieniasz et al., 1997; Choe et al., 1996) . These reports indicate that the V3 domain is important for the coreceptor usage. We previously reported that the point mutations of proline at the tip of the V3 glycine-proline-glycine-arginine (GPGR) sequence are responsible for determination of the cell tropism of HIV-1 (Shimizu et al., 1994 (Shimizu et al., , 1999b Takeuchi et al., 1991) . HIV-1 with the GPGR, GRGR, or GLGR sequence, does not infect brain-derived cells, while HIV-1 that is infectious to U87/CD4 glioma cells has either the GAGR, GSGR, or GTGR sequence. The latter three mutants use GPR1 as a coreceptor (Shimizu et al., 1999a) . CBL-23, GH-1, ROD, and SBL6669, but not CBL-20 or CBL-21, used GPR1 as a coreceptor (Fig. 1, Table 2 ). However, we could not identify a specific amino acid change that would explain the GPR1 usage by HIV-2 and SIV strains (Table 3) .
A recent study showed that the V1/V2 region of HIV-1 and the V3 loop are both necessary and sufficient to confer CCR3-tropism (Ross and Cullen, 1998) . The amino acid sequences of the V3 regions of HIV-2 and SIV strains used in this study were almost identical to those reported in the literature (Table 3) . Thus we compared the amino acid sequences of the V1 and V2 regions of phylogenetically related HIV-2 and SIVmac strains using the GenBank database. About 20% of amino acids in the V2 region are variable among each of the HIV-2 strains or SIVmac (Table 4 ). There is a markedly variable region in the middle of V2, in which the CBL-21 strain (but not the promiscuous strains) is rich in serines. The V1 se- FIG. 6 . Cell-to-cell infection of HIV-2 and SIV. C8166 human T cells (2 ϫ 10 4 ) that had been acutely infected with HIV-2ROD and SIVmnd and incubated for 3 days were overlayed onto NP-2, NP-2/CD4, NP-2/ CXCR4, or NP-2/CCR5 cells (1 ϫ 10 5 ). Twelve days after coculture, almost all C8166 cells were judged to be lysed as a result of cell damage, and then NP-2 sublines were examined for expression of HIV-2 or SIVmnd antigens by IFA.
TABLE 3
The V3 Sequences of HIV-2 and SIV Strains Used in This Study
Note. HIV-2 and SIV sequences were determined as described in Materials and Methods. Dashes are placed at positions where each sequence matches that of the consensus sequence; Dots are introduced to maintain alignments. The underlined letter, V in HIV-2ROD sequence, is different from the reported sequence (Clavel et al., 1986) . Coreceptor activities of GPCRs expressed in NP-2/CD4 and NP-2 cells as shown in Fig. 1 are summarized: Ϫ, negative; ϩ, weakly positive; ϩϩ, markedly positive. HIV-2 strains are placed by the order of width of CD4-dependent coreceptor usages.
a Soluble CD4-dependent infection.
quences of these HIV-2 strains were much more heterogeneous than were the V3 or V2 sequences (data not shown). Our sample number may be too small to identify specific sites that determine the coreceptor usage. Our findings may be summarized as follows: (1) T-cellline-adapted HIV-2 strains were grouped into two types according to their use of coreceptors other than CXCR4, and the promiscuous group (SBL6669, GH-1, CBL-23, and ROD) used multiple GPCRs; (2) this group could infect either CD4-negative NP-2/CXCR4 or NP-2/CCR5 cells in the absence (SBL6669 and ROD) or presence (all four strains) of sCD4; (3) CCR3, CCR8, GPR1, or APJ did not mediate the CD4-independent infection of HIV-1, HIV-2, or SIV; (4) GPR1 functioned as a coreceptor for SIVagm and SIVmnd, and APJ for several HIV-2 strains and SIVmnd; and (5) SIVmnd infected CD4-negative as well as CD4-positive NP-2/CCR5 cells. This complicated pattern of the coreceptor use by HIV-2 or SIV still remains to be clarified. It is also intriguing that HIV-2 showing wide cell tropism and promiscuous coreceptor usage is less pathogenic than HIV-1.
MATERIALS AND METHODS

NP-2 cells and sublines
A human glioma cell line, NP-2 (Yamazaki, 1982) , and NP-2 cells stably transduced with human CD4 (NP-2/ CD4) (Shimizu et al., 1995) were cultured in Eagle's minimum essential medium (EMEM) containing 10% fetal calf serum (FCS). NP-2 and NP-2/CD4 cells stably expressing human CCR3, CCR5, CCR8, CXCR4, GPR1, or APJ, and C8166 cells expressing CCR5 (C8166/CCR5) were established as described elsewhere (Jinno et al., 1998; Soda et al., 1999) . CCR3 and CCR5 were kindly supplied by T. J. Schall (DNAX Research Institute, Palo Alto, CA) and CXCR4, by K. Matsushima (Tokyo University, Tokyo, Japan). The cDNAs for CCR8, GPR1, and APJ were cloned by polymerase chain reaction after reverse transcription of cellular mRNA (RT-PCR) as described (Jinno et al., 1998; Shimizu et al., 1999a; Soda et al., 1999) . NP-2/CD4 cells also express the receptor for ecotropic murine leukemia virus as described previously (Jinno et al., 1998; Soda et al., 1999) . The retrovirus vector pMXpuro (Onishi et al., 1996) , containing a cDNA insert for each one of the above-listed GPCRs, was transfected into fNX-A (Grignani et al., 1998) and BOSC23 (Pear et al., 1993) packaging cells, to make pseudotype virus stocks to infect NP-2 and C8166 cells, and NP-2/CD4 cells, respectively. GPCR-transduced NP-2, C8166, and NP-2/ CD4 cells were subsequently selected in puromycincontaining medium. The cells that survived were then used to examine their susceptibilities to HIV/SIV. The expression of mRNA for each GPCR in the puromycinresistant sublines was confirmed by RT-PCR with specific primer pairs for each GPCR cDNA (data not shown). The expression of CCR3, CCR5, or CXCR4 protein on the surface of NP-2 or NP-2/CD4 cells transduced with GPCR cDNA-containing pseudotype viruses was determined by flow cytometry (FCM) using specific monoclonal antibodies (MAbs) against CCR3, CCR5, and CXCR4 as described previously (Soda et al., 1999) , and results are summarized in Table 1 .
Viruses
HIV-2 strains, CBL-20, CBL-21, CBL-23 (Schulz et al., 1990) , GH-1 , and ROD (Clavel et al., 1986) , were propagated in Molt-4#8 T cells, and the SBL6669 strain (Albert et al., 1987) , in C8166 T cells. SIV strains agmTYO-1 , mac251 (Daniel et al., 1985) , and mndGB-1 were produced by acutely infected Molt-4 cells. IIIB, a T-tropic (X4) HIV-1 strain (Popovic et al., 1984) , was produced by persistently infected Molt-4 cells. GUN1V, an HIV-1 variant that can infect brain-derived cells such as U87/CD4 and BT-20/N cells as well as T-cell lines, but hardly replicates in macrophages (Shimizu et al., 1994 (Shimizu et al., , 1999a Soda et al., 1999; Takeuchi et al., 1991) , was propagated in U87/CD4 cells. Ba-L, an M-tropic (R5) HIV-1 strain (Gartner et al., 1986) , was prepared from PHA-stimulated peripheral blood lymphocytes infected with this virus. 
CBL-21
A
Note. Reported HIV-2 and SIVmac sequences were used for comparison. Representative amino acids at each position among 6 strains are shown as the consensus sequence. Dashes are placed at positions where individual sequence matches that of the representative sequence; Dotes are introduced to maintain alignments. There is a markedly heterogeneous region in the middle: the CBL-21 strain is rich in serines there.
Flow cytometry (FCM)
Expression of CD4, CCR3, CCR5, or CXCR4 on the surface of NP-2/CD4/CCR3, NP-2/CD4/CCR5, NP-2/ CD4/CXCR4, NP-2/CCR3, NP-2/CCR5, or NP-2/CXCR4 cells was detected by FCM (Shimizu et al., 1995; Soda et al., 1999) using the following MAbs: anti-CD4, Nu-TH/I (Nichirei Bioscience, Tokyo, Japan); anti-CCR3, 7B11 (He et al., 1997) ; anti-CCR5, 2D7 (He et al., 1997) ; and anti-CXCR4, 12G5 (Pharmingen, San Diego, CA) (Endres et al., 1996) . The 7B11 and 2D7 MAbs were obtained through the AIDS Research and Reference Reagent Program, AIDS Program, NIAID, NIH. Cells were then stained with the second antibody (FITCconjugated rabbit anti-mouse immunoglobulins). The cutoff level of fluorescence intensity of each cell line was determined by which 95% were scored as being stained negative and by which 5% of the control cells (stained with the second antibody alone) were scored as being stained positive, respectively, as described previously (Shimizu et al., 1995; Soda et al., 1999) . Ratios of antigen-positive cells (%) were determined as follows: percentage of antigen-positive cells ϭ percentage of cells with fluorescence intensity that was over a cutoff value.
Infection assay of cell-free viruses
Reverse transcriptase (RT) activities of the virus stocks of HIV-1, HIV-2, and SIV strains were determined as described (Handa et al., 1991) . NP-2, NP-2/ CD4, and their GPCR-expressing sublines were seeded into 12-or 24-well culture plates at a density of 3-5 ϫ 10 4 cells/ml. On the following day, the cells were inoculated with viruses, corresponding to an RT activity of 1 ϫ 10 5 cpm, at 37°C for 2 h. The cells were washed and cultured at 37°C for up to 10 days, and the cells were passaged on Day 5. Culture medium was changed every 2-3 days. Culture supernatants were harvested in duplicate on Day 0 (2 h after infection), Day 3, and Day 5 for RT assays as described before (Handa et al., 1991) . Cell smears were made on slide glasses to detect viral antigens expressed in infected cells using indirect immunofluorescence assay (IFA) (Takeuchi et al., 1991) : anti-HIV-1 antibody-positive human serum and antiserum from an SIVmac-infected macaque, which was confirmed to react with antigens of HIV-2 and SIV strains used in this experiment, were used as the first antibodies. Stained cells were scored under a fluorescence microscope as described previously (Shimizu et al., 1999b; Soda et al., 1999) . The percentages of viral antigen-positive cells (%) were determined by counting more than 500 cells in three different fields and were expressed as means Ϯ standard deviation (SD).
Inhibition of HIV-2 or SIV infection by MAbs or chemokines
CD4-negative NP-2/CCR5 and NP-2/CXCR4 cells were seeded as described above and then pretreated with the indicated concentrations of anti-CCR5 MAb 2D7, anti-CXCR4 MAb 12G5, or a chemokine (MIP-1␣, MIP-1␤, or RANTES) for 1 h at 37°C. The cells were then infected with HIV-2ROD or SIVmnd (corresponding to an RT activity of 1 ϫ 10 4 cpm) for 2 h and cultured in the medium containing these MAbs or chemokines for 2 to 3 days at concentrations half those used for the pretreatment. The cells were then smeared onto slide glasses for IFA. Viral antigen-positive cells (%) were determined by IFA as described above. Inhibition rates (%) were calculated as follows: Inhibition (%) ϭ {1 Ϫ [MAb-or chemokinetreated culture (IFA-positive, %)/control (IFA-positive, %)]} ϫ 100.
Detection for HIV-2 or SIV infection by PCR
PCR was used to detect HIV-2 or SIV DNA synthesis after infection of NP-2 or NP-2/CD4 cells with these viruses to estimate virus entry. NP-2 and NP-2/CD4 cells were seeded into 12-well culture plates as described above. On the following day, the cells were inoculated with DNase I-treated viruses for 2 h at 37°C. The cells were then washed with PBS and cultured at 37°C for 3 days. Cell lysate samples (5 ml) were amplified by PCR with the primers specific for the conserved regions flanking the V3 domain of HIV-2, SIVagm, SIVmac, or SIVmnd. The HIV-2 primers were JA164F (5Ј-CTTCTACTTGGTTTGGCTTTAATGG-3Ј, nt 6911-6935) and JA165B (5Ј-AATTCTCCTCTGCAGTTT-GTCCACA-3Ј, nt 7277-7301); SIVagm primers, AgmN (5Ј-ATCGAACCCAGATATGGCAG-3Ј, nt 6614-6634) and AgmR (5Ј-ACAAGTTGGATGCTTCTGGG-3Ј, nt 6928-6948); SIVmac primers, MacN (5Ј-GTGCACCTCCAGG-TTATGCTTTGCTTAGATG-3Ј, nt 7283-7323) and MacR (5Ј-CAATTTGTCCACATGAAGGTAACTTCCGGAT-3Ј, nt 7739-7769); and SIVmnd primers, MndN (5Ј-GTAGC-AATATATCAGCAGTGCAGTGTACTCA-3Ј, nt 6451-6481) and MndR (5Ј-CATTTGGCAAACTCCTTTTGCTTGTC-CGTGT-3Ј, nt 6874-6904). The nucleotide sequences and numbers (nt) were referred to the following GenBank accession numbers: HIV-2, A05350; SIVagm, E02137; SIVmac, M76764; and SIVmnd, M27470.
DNA sequencing
The PCR products of HIV/SIV described above were cloned into a TA cloning vector, pCR2.1 (Invitrogen, Carlsbad, CA). Clones containing inserts were sequenced using Texas Red-labeled M13 forward and reverse primers. A Hitachi SQ-5500 automated DNA sequencer and software (Hitachi, Tokyo, Japan) were used to determine DNA sequences as previously described (Jinno et al., 1998) .
